Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC

NCT01215474 is registered in ClinicalTrials.gov with Provitro GmbH as lead sponsor.

NCT NCT01215474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01215474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC
Lead sponsor
Provitro GmbH
Phase
Observational
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mutations in exons 18 to 21